Celgene Corporation (NASDAQ:CELG)
Company Conference Presentation
November 15, 2016, 08:45 AM ET
Executives
Scott Smith - President, Global I&I
Analysts
Katherine Breedis - Stifel, Nicolaus & Co., Inc.
Operator
Question-and-Answer Session
Q - Katherine Breedis
All right, good morning everyone. All right, well thank you so much for joining us. I am Katherine Breedis, the Major Pharm and Biotech analyst here at Stifel. We're pleased to have Scott Smith, the President of Celgene's Inflammation and Immunology business and since we're running a few minutes late we might as well just kick it off with some questions.
